Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · Real-Time Price · USD
0.4476
+0.0336 (8.12%)
At close: Mar 9, 2026, 4:00 PM EDT
0.4231
-0.0245 (-5.47%)
After-hours: Mar 9, 2026, 5:48 PM EDT
OTLK's stock price has decreased by -69.96% in the past year and price targets may not have had time to catch up.
Outlook Therapeutics Analyst Ratings
Total Analysts
4
Consensus Rating
Buy
Price Target
$3.83
Upside
+755.67%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $0.5 | Hold | Reiterates | $0.5 | +11.71% | Feb 18, 2026 |
| Chardan Capital | Chardan Capital | Hold Maintains $1 | Hold | Maintains | $1 | +123.41% | Feb 18, 2026 |
| Chardan Capital | Chardan Capital | Hold Maintains $3 → $1 | Hold | Maintains | $3 → $1 | +123.41% | Jan 5, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $1 → $0.5 | Hold | Maintains | $1 → $0.5 | +11.71% | Jan 2, 2026 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $8 → $10 | Strong Buy | Maintains | $8 → $10 | +2,134.14% | Dec 22, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $1 | Hold | Reiterates | $1 | +123.41% | Sep 30, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $21 → $8 | Strong Buy | Maintains | $21 → $8 | +1,687.31% | Sep 22, 2025 |
| Guggenheim | Guggenheim | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Aug 29, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades $1 | Strong Buy → Hold | Downgrades | $1 | +123.41% | Aug 29, 2025 |
| Chardan Capital | Chardan Capital | Hold Maintains $3 | Hold | Maintains | $3 | +570.24% | Aug 28, 2025 |
| Chardan Capital | Chardan Capital | Hold Maintains $3 | Hold | Maintains | $3 | +570.24% | Aug 15, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $24 → $21 | Strong Buy | Maintains | $24 → $21 | +4,591.69% | Jun 6, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $33 → $24 | Strong Buy | Maintains | $33 → $24 | +5,261.93% | Feb 24, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $30 → $3 | Strong Buy | Maintains | $30 → $3 | +570.24% | Feb 18, 2025 |
| Chardan Capital | Chardan Capital | Hold Maintains $3 | Hold | Maintains | $3 | +570.24% | Feb 18, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +2,580.97% | Jan 17, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.